ArticleWomen's health (London, England)
A survey of reproductive anatomy and gender affirming hysterectomy knowledge among transgender men who started testosterone at or before 18 years old.
Article in Women's health (London, England). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BackgroundFor many transgender young adults considering gender affirming hysterectomy, discussions may begin prior to the age of 18. However, the extent of their relevant understanding is unclear.ObjectivesDetermining whether transgender men who started testosterone during adolescence correctly understand their reproductive anatomy and the nature and implications of hysterectomy with or without oophorectomy as well as the extent of their recalled counseling and related beliefs.DesignCross-sectional survey.MethodsAn anonymous REDCap survey, sent both through community message boards and the Prolific survey platform, assessing knowledge of and experiences with reproductive and sexual health care in the context of gender affirming care. Analyses were descriptive.ResultsOf 125 respondents, most had initiated testosterone between age 17 and 18 (n=85,6
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.